This paper presents certain simple procedures for assessing the most common types of interference, due to hasmolysis, icterus or lipaemic serum in 19 routine Clinical Chemistw tests and suggests steps to overcome the problem in some tests. A Change in the measured concenUation, to be analytically significant, had to exceed 2.8 X % coefficient of variation (cv) of the intra-assay analytical variation of each assay. Haemolysis caused interference in 10 of the 19 assays investigated. A haemolysate haemoglobin concentration of 0.29 g/dl, visible to the eye, caused an analytically significant increase in creattnine kinase MB subunit (CKMB), lactate dehydrogenase (LDH), total protein, trlglyceride, uric arid and urea, and a significant decrease in alkaline phosphatase (ALP), and total bilirubin. A higher conoentratlon of haemoglobin (0.68 gl dl) caused an additional significant increase in CK, and a decrease in direct bilirubin. Addition of bilirubin caused interference in all the peroxidase linked reactions as well as in the cmatinine assay. At a serum concentration of 5.2 mg/dl it caused a decrease in creatinine, glucose, trlglycedde and udc acid. At a higher concentration (15.9 mgldl) it also decreased cholesterol. Lipaemia interference affected the least number of assays. An added triglycaride of 537-561mg/dl caused an increase in glucose, uric acid, and amylase. At a level of 1122 mgldl it also increased CKMB, and at a value of 2244 mg/dl it increased total and direct bilirubin. At the highest levels of hasmolysis and lipsemia, the serum glutamate oxaloacetate transaminase (GOT) and glutamate pyruvate transaminase (GPT) gave erratic results. Overall uric acid and CKMB were the analytss most susceptible to interference, while serum calcium and phosphate did not suffer from any. The interference depends on the exact assay conditions used and the susceptibility of each individual laboratory's tests should be detmmined by them. The reasons for the Intmforences described are discussed.
INTRODUCTION
The most corrwnon types of irtedemnce in routine clinical chemistry tests are caused by haemolysis, icterus and lipaemia. In the era of manual methods and before discrete analyse~ were widely used, the measurement of severeiy haemolvsed, icteric or lipaemic specimens was possible using blank ~ deproteinization and dalysis on contJnous flow analysers. The limitations of discrete analyzers Author for correspondence: Dr. J.J. Fleming at above address in their susceptibility to interference are well recognized.
IntB/emrce in routine dinical chernislry analysis has been defined in different ways.Chemical interference can be defined as "the effect of a substance ~ in the sample tt~t alters the correct value of ttle result usually expmsssd as c(xcert~on or activity for an analyte" (1) . According to Castano-V'~iales (2) , the definition of chemical encompasses drugs, metabolites, contaminants, intracellular constituents, the solution matrix etc., and "chemical interference can be defined as a deviation from the result expected for a given cormentra~on of analyte ~ by the presence of another chemical species in the sample." The International Union of Pure and Applied Chemistry (IUPAC) (quoted in ref.
2) have defined it as follows "an interfering substance in an analyUcal procedure causes, at a given corcentra'don, a systematic error in the analytical result. In the case of a quan'dta~e determination an error attribul~e to intederence has to be greeter than a multiple of the SD obtained in the absBce of the subslartce (a value of 3 SD is used).
The classical apprcach to eval, =a,=-a new meltx~d is to add the interferent material directly to a large pool of serum and measure the resu~ This is limited by the fact that the matrix of the pooled sample may not ~ a typical pathological spearnen and the substance added may not be iderfdcal to the interferent in the pathological specimen. Alternatively a series of icteric, turbid and hasmolysed specimens may be analysed by the method to be studied and by an established methe~ freefrom such interferences. This can best be done by analyzing a series of saml:~S that vary only in the concentration of the interferent and studying the linear and non-linear regression line. This model assumes that all intereference is independent of the concenfz~on of the analyte, wttch is not the case. Interference may be analytedependent, analyte-irldependent or a combination of both (1) . It may also be defined as similar (chemical or spectral), different (analyte dependent), or nonspecific (2), with matrix effects being a composite of all the i~ caused by the presence of crdferent anions, cations and organic constituents of the sample.
As instnJrnents and analy~cal methods improve in India, individual instruments and methods should be evaluated for their susceptibility to ~ and oltNsr types of interference. There has been a tendency to assume tt~t good analys~ produce good results, but actually the results are only as good as the analytical methods in use. Analysers cannot correct for defi~ inherent in methodology. For example the serum uric acid assay uses an enzymic method where uricase has great specificity for uric acid, it is however mined by having a non-specifice detector reason with peroxidase (3). This paper ~ a sedas of simple procedures for assessing interfenmce in routine clinical chemistry tests and suggests steps to overcome intederence in some tests.
MATERIAL8 AND METHOD8
The BM/Hitachi 912 analyser (Boehringer Mannheim, ~) was used to carry out all the measurements, e~o~pt for gi,___,~__ and amylme wtVch wsre performed on the Hitachi 911 analyser. AJlI~ 19 routine chemistries were carried out using procedures and reagents described by BM in their me~ literature (see ~ for detaits and full list of abbreviations used for each test ). The alternative method used to measure creatinine in specimens with a high bilirubin ~as the Boehdnger Mannhelm HiCo cmatinine twin mode assay, using two channels on the autoanalyser. Both are kinetic reactions and the blank rate is used to compensate the test rate. The methods dascrtbed below are standard procedures used to prepare haemolys~e etc, and were dedved from those of Kazmierczak et al (4) . Pooled serum forthe studiaswore prepemd by mixing clear sera, previously analysed and known to have nom~l or near normal values f~r the analytas to be tested. This matedal must be assumed to be poter~ally infectious and treated with appropriate caution. In later studies clear previously~ sere with i~ valuas of s0me analytas to be assessed were used. Initially two conce~b-a~ions of all the inter~~ml:X'ep~, later pools~dth 3 levels oftriglyomdeand4 levels of in(xeasing bllirubln ~re ~.
All ltte analy~_ __ were ~ on bhe ~T,e day as the interferent pools ~ prepared.
Preparation ofsera wtth incrmming hmNnolysls
The influenca of haemoly~s v~s stud~d by adding haemolysate to a pool of human sera. Five rnts of lithium hepednate blood was cor~ for 10 rains at approximately 3000rpm., and the plasma separated. A volume of 0.4 ml of the red cells was taken and 4 ml of 0.9% saline added. The mixture
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Intederence in autoanalyzer analysis ~es shaken and again cenbifuged for 10 rrmJtes The ~=hing ~ was repealed twice. The =4mmalant ~gs removed, then 2ml of distilled ~eter added to the cells. After leaving for 15 minsat 4~ to disrupt the red cells, the mixture ~es centrifuged for 10 minutes to remove cell debds. A small sample of the haemolysis diluent was analysed for haemoglobin, then the haemolysate added to the serum pool according to the following scheme. 
Preparation of sera with increasing concentrations of bilirubin
To study the influence of hyped)ilirublnaemia a serum or plasma pool hesto be spiked with a bilirubin solution. Notethe serurn pool used will have bilirubin present already, this will be the base value. Approximately 15 mg of bilirubln was weighed in a vial _lxotec#~___ from light, 1.25 ml of 0.1 M NaOHwas added and it was left for 5 rains to dissolve. After dissolution of the bilirubin, 3.75 ml of distilled water v~s added and the soluUon ~ from light using aluminium foil. It was used as soon as possible. The blliruUn solution ~Aas added to a serum pool according to the following scheme: In the case of bilirubin and haemoglobin the inter~ was in a fixed volume 100FI to 9001A of serum, so tube 1 is directly comparable with the other tubes. In the initial study only tubes 1,2 and 5 ~'e used. For the initial study the intralipld pool was as a 7:100 dilution (701d Int~ipid v~s made upto lml with a serum pool). The diluUons of this lipid solution ~'e 3:7 and l:7withtheserum pool. Since the upper detection limit of the TG assay is 1000 mg/ di, the appm t ycedde concemra of the tubes was oblained from the 1:7or 1:8 diluIJon of the i, =b~;ipid pool and the ~ ofthe other pools is~rked out as muffiples of that value. The ratio of serum pool to intralipid pool could not be kept constant so tube 1 does not exac~ ~e the pools with added lipid.
Preparation of sera with Increasing concentrations of triglycedde

RESULTS
In the initial i~ studies the hasmolysate pool haemoglobin concentration was 9.7 g/dl, and the bilirubin spiking solution approximately 250 mg/ dl. In the initial studies, using two concentrations of intederent, all the analyte levels in the base sera were within normal limits except for cmatinine 2.6 mg/dl The analytes where there was a significant intederence from i~lirubin in the first sludy were CREA, CHOL, GLU, TG and UA. TP showed a significant decrease to 92.4% of its odginal value and CKMB increased to 140% of its odginal value at a bilirubin concentration of 23.5 mg/di. These changes were not Note: the effect of added haemolysate on LDH (100, 237, 367%), and on CKMB (100, 670, 1290%) is not shown co m pletely further investigated in the second study. For triglyceride interference in the initial study the analytes where a significant change was seen were AMY, BIL-T, D-BIL, CK, CKMB, GLU, LDH and UA. The second study was a more detailed study of bilirubin and tdglycedde interference on these respective analytes using a series of 4 increasing bilirubin concentrations and 3 increasing tdglycedde concentrations. In the second biUrubin study, the concentration of uric acid (9.4 mg/dl) and glucose (214 mg/dl) was abnormal.
The activity of amylase in this triglycedde study was also abnormal (259 U/I).
In the first study, GOT and GPT activity measurement at the highest level of haemolysis was not reliable because the absorbance exceeded the analyzer limit of 3.3. The initial values in the base serum pool of both of them were <30 U/I. These values fell by 5 UIL at the highest level of bilirubin interference. The subsequent bilirubin study used a serum pool with much higher levels of GOT and GPT (363 and 288 U/I). Here no change was observed in activity, even at a bilirubin concentration of 24.2 mg/ dl. With the highest value of triglycedde (2148 mg/ dl), the GOT and GPT could not be quantitated accurately, because of en'atic readings. LDH activity was significantly decreased to 91% of its original value with a triglycedde concentration of 2148 g/dl in the initial study. However in the second study values rose to 113% of its original value with a tdglycedde concentration of 561 mg/dl and upwards. Since these changes were not consistent they were not included. The data from second study of interference from bilirubln and triglyceride, where there was a significant change in analyte concentration are plotted in figure 2-3 as interferographs (5). Table 1 is a summary of the data from all the studies, showing the concentration of interferent above which a significant effect was observed on the analytes listed. There was a good agreement between the two methods when the bilirubin was low. but the existing method has a negative bias at a high bilirubin concentration.
DISCUSSION
Further experiments were carried out on the measurement of creatinine by the existing method and a new method not susceptible to bUirubin interference. Twenty one specimens with a bilirubin <3.0 mg/dl were analysed, and 18 specimens where the bUirubin was > 14.2 mg/dl. This data is plotted in
The simplest way to present all the data presented in this study is by using interferograms (5). They can be used to compare different assays on the same analyzer orthe same assay on different anlysers and have generally been dedved by evaluating the effect of the interferent on only one concenb'ation of analyte. In this study usually only analyte concentrations within the normal range were used, except for creatinine, glucose, GOT, GPT and uric acid where different concentrations were evaluated. Extrapolation of the effect of an interferent from one concentration of analyte to other concentrations may be highly inaccurate and misleading when applied to analytes for which interference is dependent on the analyte concentration(4).
In this study, the additi()n of increasing concentrations of bilirubin (5.2 mg/dl) to pooled sera has a significant negative effect on the concentration of creatinine, uric acid, triglycedde, and glucose. There is an effect on cholesterol from a bilirubin of 15.9 mg/ dl upwards. Except for creatinine, these are all analysed by peroxidase--coupled enzymatic methods. Both conjugated and unconjugated bilirubin have a strong absorbance between 400-500nm, and can interfere in analyses carried out between these wavelengths. In addition to a positive spectral interference there is a greater negative interference, due to the consumption of hydrogen peroxide or a chromogen intermediate, by the bilirubin. The uric acid assay used here was the most subject to interference, and its measurement has been reviewed in detail (3). It is stated that the presence of potassium ferrocyanide may overcome interference by causing hydrogen peroxide to oxidize ferrocyanide to ferdcyanide. This ferricyanidethen oxidizesthe chromogen via a phenol intermediate that does not react with bilirubin (3). In the case of glucose analysis, a study was carded out (6) which suggests the incorporation of potassium ferdcyanide and bUirubin oxidase in the assay mixture. In practice we need to be aware of the existence of bilirubin interference and take great care in reporting affected results to the requesting clinician.
Interference of bilirubin in the determination of creatinine by the Jaffe reaction is also well documented (7). Bilirubin is oxidized to biliverdin by the alkaline conditions and causes a decrease in absorbance at 510rim. The magnitude of the interference is dependant on the bilirubin concentration regardless of the creatinine concentration. So the greatest interference is at low creatinine concentrations. The magnitude of decrease depends on the bilirubin concentration, not the creatinine concentration i.e interferent dependant. It was analytically significant (-0.3 mg/dl) for a measured creatinine of 2.6 mg/dl, but even though the change was bigger (-0.6 mg/dl) in a sample with a base creatinine of 13.5 mg/dl, this was not analytically significant as a percentage. Autoanalyser methods using a kinetic creatinine assay are prone to this interference. It is necessary to be able to take a kinetic serum blank during the course of the reaction eg Boehringer Manheim HiCo creatinine assay. HPLC and Kodak Ektachem methods are also unaffected by bilirubin. If the assay is carried out manually on these specimens, addition of acid at the end of the reaction destroys colour produced by creatinine and overcomes this problem.
Kroll et al (1) assessed haemoglobin interference in 3 different assays. It was either independent of analyte concentration (creatinine), dependent on analyte concentralion (total bilirubin) or a combination of both (direct bilirubin). In this study, there was no effect of haemolysis on the phosphate concentration of the pooled sera even at an Hb concentration of 0.68 g/dl., even though phosphate is released from haemolysis of red cells. The effect on ALP assays is probably also due to spectral interference at the assay wavelength of 415nm. When haemoglobin is oxidized to metHb it causes a decrease in absorbance at 340nm, so it can effect any method using this wavelength. This explains the absorbance >3.3 in the GOT and GPT __ _~_~P~_~j s_ at a haemoglobin concentration of 0.68 g/dl, which made the results unreliable.
The mechanism of haemoglobin interference in the bilirubin assay is described by Westwood (8) . It may interfere chemically causing destruction of bilirubin prior to reaction, directly interfere in the diazo (~q:~ling r~lion, a'~l d~boy U'~ f'~m~ az~ All these effects vary depending on the exact assay conditions. The increase observed in the TP a-__~__y corresponds almost directly to the increase in haemoglobin pro~n ~, i:x~ the expla~3tion for the effect of haemolysis on albumin and urea is not clear, it is either spectral or chemical or a combination. Brady and O'Leary (10), have documented interference from haemoglobin in a wide range of assays on a number of adomated inslnaT~-d~ by distributing a quality control specimen containing 0.5 g/cU haemoglobin.
Lipaemia is visible in serum because of the light scattering effects of VLDL particles and chylomicrons. The turbidity causes a high background reading in many assays, especially those using only a single reading at the end of the _a~___y (1 point). This will cause a falsely high reading because no blank correction is available. However this can be overcome by measuring a true sample blank in the course of the reaction or use of a 2 reagent procedure that takes an eady reading of the specimen mixed with the first reagent 1, before the addition of the second reagent and the reaction proceeds The assay most prone to this interference is uric acid. The problem can be overcome using commercial as_~3_ys with a lipid clearing factor in the reagents. Filtration of lipaemic specimens through a 0.451~m cellulose nitrate filter, followed by fiib~,ion through a 0.1pro filter may remove the background interference of chylomicrons and commercial lipid clearing solutions are also available for this pu _rpose__-.
Lipaemia also causes displacement of plasma water, giving falsely low values for sodium in flame photometry methods. Many enzymic methods incorporate detergents which clear lipoprotelns and will progressively alter the absorbance rate being measured. One of the ___~, -_~=ys_ affected bythisdearing is ~glycedde itself, since lipase will ~ely dear lipaemic specimens causing a decrease in absorbance. As the wavelength being monitored decreases, the apparent absorbance due to lipaemia increases. According to Brady and O'Leary (11) single bichromatic autoanalyser methods are very poor in measuring lipaemic samples and a kine'dc procedure or method incorporating a true sample blank is better. They studied the effect of lipaemia 1000mg/dl on a wide range of as_~_ys and automated instruments.
The effect of parapmteins, drugs and the whole area of interference in immunoas_r will not be discussed here, although they may have a major interference in assays. Interference in dinical chemical analysis has been reviewed by Saibaba et al (12) . The clinical biochemist must always be on the alert for possible assay interferences, which might compromise the quality of service being provided. When using commercial methods, kit inserts usually alert the user to possible interference. Diluting the specimens with salinemay reduce the concentration of interferent to belowa level at which it can chemically affect the assay, but will not reduce spectral or background interference as the ratio of corcentration 
